Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Alopecia | x | ||
| Amenorrhoea | x | ||
| Anxiety | x | ||
| Clotting | x | ||
| Libido decreased | x | ||
| Gynaecomastia | x | ||
| Headache | x | ||
| Haemorrhage | x | ||
| Hirsutism | x | ||
| Jaundice cholestatic | x | ||
| Nausea | x | ||
| Oligospermia | x | ||
| Peliosis hepatis | x | ||
| Polycythaemia | x | ||
| Angiopathy | x | ||
| Virilism | x | ||
| Paresthesia generalized | x | ||
| Enlarged clitoris | x | ||
| Menstruation irregular | x | ||
| Anaphylactoid reaction | x | ||
| Cholesterol serum elevated | x | ||
| Venous thromboembolism | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |